Hobart Laboratories
Private Company
Funding information not available
Overview
Hobart Laboratories is a century-old, private company with a niche focus on legacy topical analgesic products sold under the Numotizine® brand for human and animal use. The company operates with a simple, asset-light business model centered on manufacturing and distributing its two core products: a medicated clay poultice for animals and an FDA-approved menthol-infused ointment for personal care. It leverages a long-standing reputation, direct-to-consumer online sales, and a network of distributors to serve a loyal customer base of equine professionals, athletes, and retirees. The company's strategy is built on brand legacy, consistent quality, and geographic expansion through established retail channels.
Technology Platform
Proprietary, legacy formulations for topical analgesic poultices and ointments, manufactured in an FDA-regulated facility. No modern discovery or biologics platform.
Opportunities
Risk Factors
Competitive Landscape
In the human OTC analgesic market, it competes with mass-market brands like Bengay, Icy Hot, and Aspercreme. In the equine and animal care market, it competes with other topical poultice brands (e.g., Absorbine, Sore No-More) and larger animal health companies. Its competitive edge is its long history, specific brand loyalty in equine circles, and its unique positioning as a product trusted for both humans and animals.